Literature DB >> 19923899

Visualization and enrichment of live putative cancer stem cell populations following p53 inactivation or Bax deletion using non-toxic fluorescent dyes.

Joshua E Allen1, Lori S Hart, David T Dicker, Wenge Wang, Wafik S El-Deiry.   

Abstract

Putative cancer stem cell (CSC) populations efflux dyes such as Hoechst 33342 giving rise to side populations (SP) that can be analyzed or isolated by flow cytometry. However, Hoechst 33342 is highly toxic, more so to non-SP cells, and thus presents difficulties in interpreting in vivo studies where non-SP cells appear less tumorigenic than SP cells in immunodeficient mice. We searched for non-toxic dyes to circumvent this problem as well as to image these putative CSCs. We found that the fluorescent dye calcein, a product of intracellular Calcein AM cleavage, is effluxed by a small subpopulation, calcein low population (C(lo)P). This population overlaps with SP and demonstrated long term cell viability, lack of cell stress and proliferation in several cancer cell lines when stained whereas Hoechst 33342 staining caused substantial apoptosis and ablated proliferation. We also found that the effluxed dye D-luciferin exhibits strong UV-fluorescence that can be imaged at cellular resolution and spatially overlaps with Calcein AM. In order to evaluate the hypothesis that p53 loss promotes enrichment of putative CSC populations we used Calcein AM, D-luciferin and Mitotracker Red FM as a counterstain to visualize dye-effluxing cells. Using fluorescence microscopy and flow cytometry we observed increased dye-effluxing populations in DLD-1 colon tumor cells with mutant p53 versus wild-type (WT) p53-expressing HCT116 cells. Deletion of the wild-type p53 or pro-apoptotic Bax genes induced the putative CSC populations in the HCT116 background to significant levels. Restoration of WT p53 in HCT116 p53(-/-) cells by an adenovirus vector eliminated the putative CSC populations whereas a control adenovirus vector, Ad-LacZ, maintained the putative CSC population. Our results suggest it is possible to image and quantitatively analyze putative CSC populations within the tumor microenvironment and that loss of pro-apoptotic and tumor suppressing genes such as Bax or p53 enrich such tumor-prone populations.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19923899      PMCID: PMC2975270          DOI: 10.4161/cbt.8.22.10450

Source DB:  PubMed          Journal:  Cancer Biol Ther        ISSN: 1538-4047            Impact factor:   4.742


  61 in total

1.  Flow cytometric analysis of neural stem cells in the developing and adult mouse brain.

Authors:  Ayako Murayama; Yumi Matsuzaki; Ayano Kawaguchi; Takuya Shimazaki; Hideyuki Okano
Journal:  J Neurosci Res       Date:  2002-09-15       Impact factor: 4.164

2.  Cells of the hepatic side population contribute to liver regeneration and can be replenished with bone marrow stem cells.

Authors:  Gerald G Wulf; Kang-Li Luo; KathyJo A Jackson; Malcolm K Brenner; Margaret A Goodell
Journal:  Haematologica       Date:  2003-04       Impact factor: 9.941

3.  Prospective identification of tumorigenic breast cancer cells.

Authors:  Muhammad Al-Hajj; Max S Wicha; Adalberto Benito-Hernandez; Sean J Morrison; Michael F Clarke
Journal:  Proc Natl Acad Sci U S A       Date:  2003-03-10       Impact factor: 11.205

4.  Suppression of induced pluripotent stem cell generation by the p53-p21 pathway.

Authors:  Hyenjong Hong; Kazutoshi Takahashi; Tomoko Ichisaka; Takashi Aoi; Osami Kanagawa; Masato Nakagawa; Keisuke Okita; Shinya Yamanaka
Journal:  Nature       Date:  2009-08-09       Impact factor: 49.962

5.  The cyclin-dependent kinase inhibitor butyrolactone is a potent inhibitor of p21 (WAF1/CIP1 expression).

Authors:  Joanna K Sax; Bipin C Dash; Rui Hong; David T Dicker; Wafik S El-Deiry
Journal:  Cell Cycle       Date:  2002-01       Impact factor: 4.534

6.  Regulation of the Mdr1 isoforms in a p53-deficient mouse model.

Authors:  Jason A Bush; Gang Li
Journal:  Carcinogenesis       Date:  2002-10       Impact factor: 4.944

7.  Sca-1(pos) cells in the mouse mammary gland represent an enriched progenitor cell population.

Authors:  Bryan E Welm; Stacey B Tepera; Teresa Venezia; Timothy A Graubert; Jeffrey M Rosen; Margaret A Goodell
Journal:  Dev Biol       Date:  2002-05-01       Impact factor: 3.582

8.  Bioluminescent molecular imaging of endogenous and exogenous p53-mediated transcription in vitro and in vivo using an HCT116 human colon carcinoma xenograft model.

Authors:  Wenge Wang; Wafik S El-Deiry
Journal:  Cancer Biol Ther       Date:  2003 Mar-Apr       Impact factor: 4.742

9.  Dissecting p53 tumor suppressor functions in vivo.

Authors:  Clemens A Schmitt; Jordan S Fridman; Meng Yang; Eugene Baranov; Robert M Hoffman; Scott W Lowe
Journal:  Cancer Cell       Date:  2002-04       Impact factor: 31.743

10.  Myogenic specification of side population cells in skeletal muscle.

Authors:  Atsushi Asakura; Patrick Seale; Adele Girgis-Gabardo; Michael A Rudnicki
Journal:  J Cell Biol       Date:  2002-10-14       Impact factor: 10.539

View more
  5 in total

Review 1.  Therapeutic targeting of the p53 pathway in cancer stem cells.

Authors:  Varun V Prabhu; Joshua E Allen; Bo Hong; Shengliang Zhang; Hairong Cheng; Wafik S El-Deiry
Journal:  Expert Opin Ther Targets       Date:  2012-09-24       Impact factor: 6.902

2.  AA-NAT, MT1 and MT2 Correlates with Cancer Stem-Like Cell Markers in Colorectal Cancer: Study of the Influence of Stage and p53 Status of Tumors.

Authors:  Jorge Casado; Almudena Iñigo-Chaves; Sergio M Jiménez-Ruiz; Sandra Ríos-Arrabal; Ángel Carazo-Gallego; Cristina González-Puga; María Isabel Núñez; Ángeles Ruíz-Extremera; Javier Salmerón; Josefa León
Journal:  Int J Mol Sci       Date:  2017-06-11       Impact factor: 5.923

Review 3.  Plasticity and Potency of Mammary Stem Cell Subsets During Mammary Gland Development.

Authors:  Eunmi Lee; Raziye Piranlioglu; Max S Wicha; Hasan Korkaya
Journal:  Int J Mol Sci       Date:  2019-05-13       Impact factor: 5.923

Review 4.  Mutant p53 Gain-of-Function: Role in Cancer Development, Progression, and Therapeutic Approaches.

Authors:  Eduardo Alvarado-Ortiz; Karen Griselda de la Cruz-López; Jared Becerril-Rico; Miguel Angel Sarabia-Sánchez; Elizabeth Ortiz-Sánchez; Alejandro García-Carrancá
Journal:  Front Cell Dev Biol       Date:  2021-02-11

5.  Calcein-effluxing human colon cancer cells are enriched for self-renewal capacity and depend on β-catenin.

Authors:  Joshua E Allen; Wafik S El-Deiry
Journal:  Oncotarget       Date:  2013-02
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.